nach oben

Erschienen in:

01.10.2020 | Clinical study

ADR reporting by patients increased by use of a mobile app

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Reporting of ADRs by patients with multiple sclerosis (MS) receiving a first-line disease-modifying drug (DMD) can be increased by the use of a mobile device app, according to the results of a study from France. …

Defer G, et al. Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial. Drug Safety : 13 Oct 2020. Available from: URL: https://doi.org/10.1007/s40264-020-01009-z

Titel: ADR reporting by patients increased by use of a mobile app
Publikationsdatum: 01.10.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-84762-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

ADR reporting by patients increased by use of a mobile app

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Bevacizumab/capecitabine/fluorouracil

Non-serious case reports

Ruxolitinib

Doxorubicin-liposomal/etoposide/methylprednisolone

Antineoplastics

Cytarabine/daunorubicin